Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co., Ltd.
  • liver test kit
  • liver test kit

Liver Disease Assay (ELISA) Kit

The latest global cancer burden data (Globocan 2020) shows that primary liver cancer is the sixth most common malignancy.Globally, an estimated 905,700 people are diagnosed with liver cancer and 830,200 die from it.More than half of the world's estimated liver cancer cases and deaths occur in East Asia (54.3% and 54.1%, respectively).

Liver diseases are progressive disease, so early diagnose and timely treatment is important way to stop it.


Specification of Liver Disease Assay (ELISA) Kit

PanelParameterRegistration certificateSample type
Liver diseaseHBV-LPNMPAS/P
GP73NMPA, CES/P
AFPNMPA, CES/P
DCPNMPA, CES


Products
Want to Get More Details about lVD Products?

Discover the precision and reliability of Hotgen IVD products. Contact us today to enrich your product portfolio & enhance your diagnostic capabilities and patient care.